Cargando…
FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND ME...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604080/ https://www.ncbi.nlm.nih.gov/pubmed/26462160 http://dx.doi.org/10.1371/journal.pone.0140222 |
_version_ | 1782394999202119680 |
---|---|
author | Llauradó, Gemma Megia, Ana Cano, Albert Giménez-Palop, Olga Simón, Inmaculada González-Sastre, Montserrat Berlanga, Eugenio Fernández-Veledo, Sonia Vendrell, Joan González-Clemente, José-Miguel |
author_facet | Llauradó, Gemma Megia, Ana Cano, Albert Giménez-Palop, Olga Simón, Inmaculada González-Sastre, Montserrat Berlanga, Eugenio Fernández-Veledo, Sonia Vendrell, Joan González-Clemente, José-Miguel |
author_sort | Llauradó, Gemma |
collection | PubMed |
description | OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND METHODS: 68 T1DM patients and 68 age- and sex-matched controls were evaluated for 1) age, sex, diabetes duration, physical activity, smoking, alcohol intake, BMI, blood pressure, fasting plasma glucose, HbA(1c), estimated glomerular filtration rate (eGFR) and lipid profile; 2) microvascular complications; 3) blood concentrations of FGF-23 and mineral metabolism parameters (calcium, phosphate, parathyroid hormone (PTH) and 25-hydroxy-vitamin D (25(OH)D)); 4) AS, assessed as aortic pulse wave velocity (aPWV); and 5) low-grade inflammation (hsCRP, IL-6, sTNFαR1, sTNFαR2) and endothelial dysfunction (ED) markers (ICAM-1, VCAM-1, E-Selectin). RESULTS: Patients with T1DM had higher aPWV compared with controls (p<0.001), but they did not present differences in 25(OH)D (70.3(50.4–86.2)nmol/L vs. 70.7(59.7–83.0)nmol/L; p = 0.462) and in FGF-23 plasma concentrations (70.1(38.4–151.9)RU/mL vs. 77.6(51.8–113.9)RU/mL; p = 0.329). In T1DM patients, higher concentrations of FGF-23 were positively associated with aPWV after adjusting for eGFR and classical cardiovascular risk factors (model 1: ß = 0.202, p = 0.026), other mineral metabolism parameters (model 2: ß = 0.214, p = 0.015), microvascular complications, low-grade inflammation and ED markers (model 3: ß = 0.170, p = 0.045). Lower 25(OH)D concentrations were also associated with higher aPWV after adjusting for all the above-mentioned factors (model 3: ß = -0.241, p = 0.015). CONCLUSIONS: We conclude that both FGF-23 plasma concentrations (positively) and 25(OH)D serum concentrations (negatively) are associated with AS in patients with T1DM and no previous cardiovascular events. |
format | Online Article Text |
id | pubmed-4604080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-46040802015-10-20 FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness Llauradó, Gemma Megia, Ana Cano, Albert Giménez-Palop, Olga Simón, Inmaculada González-Sastre, Montserrat Berlanga, Eugenio Fernández-Veledo, Sonia Vendrell, Joan González-Clemente, José-Miguel PLoS One Research Article OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND METHODS: 68 T1DM patients and 68 age- and sex-matched controls were evaluated for 1) age, sex, diabetes duration, physical activity, smoking, alcohol intake, BMI, blood pressure, fasting plasma glucose, HbA(1c), estimated glomerular filtration rate (eGFR) and lipid profile; 2) microvascular complications; 3) blood concentrations of FGF-23 and mineral metabolism parameters (calcium, phosphate, parathyroid hormone (PTH) and 25-hydroxy-vitamin D (25(OH)D)); 4) AS, assessed as aortic pulse wave velocity (aPWV); and 5) low-grade inflammation (hsCRP, IL-6, sTNFαR1, sTNFαR2) and endothelial dysfunction (ED) markers (ICAM-1, VCAM-1, E-Selectin). RESULTS: Patients with T1DM had higher aPWV compared with controls (p<0.001), but they did not present differences in 25(OH)D (70.3(50.4–86.2)nmol/L vs. 70.7(59.7–83.0)nmol/L; p = 0.462) and in FGF-23 plasma concentrations (70.1(38.4–151.9)RU/mL vs. 77.6(51.8–113.9)RU/mL; p = 0.329). In T1DM patients, higher concentrations of FGF-23 were positively associated with aPWV after adjusting for eGFR and classical cardiovascular risk factors (model 1: ß = 0.202, p = 0.026), other mineral metabolism parameters (model 2: ß = 0.214, p = 0.015), microvascular complications, low-grade inflammation and ED markers (model 3: ß = 0.170, p = 0.045). Lower 25(OH)D concentrations were also associated with higher aPWV after adjusting for all the above-mentioned factors (model 3: ß = -0.241, p = 0.015). CONCLUSIONS: We conclude that both FGF-23 plasma concentrations (positively) and 25(OH)D serum concentrations (negatively) are associated with AS in patients with T1DM and no previous cardiovascular events. Public Library of Science 2015-10-13 /pmc/articles/PMC4604080/ /pubmed/26462160 http://dx.doi.org/10.1371/journal.pone.0140222 Text en © 2015 Llauradó et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Llauradó, Gemma Megia, Ana Cano, Albert Giménez-Palop, Olga Simón, Inmaculada González-Sastre, Montserrat Berlanga, Eugenio Fernández-Veledo, Sonia Vendrell, Joan González-Clemente, José-Miguel FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness |
title | FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness |
title_full | FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness |
title_fullStr | FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness |
title_full_unstemmed | FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness |
title_short | FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness |
title_sort | fgf-23/vitamin d axis in type 1 diabetes: the potential role of mineral metabolism in arterial stiffness |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604080/ https://www.ncbi.nlm.nih.gov/pubmed/26462160 http://dx.doi.org/10.1371/journal.pone.0140222 |
work_keys_str_mv | AT llauradogemma fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT megiaana fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT canoalbert fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT gimenezpalopolga fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT simoninmaculada fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT gonzalezsastremontserrat fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT berlangaeugenio fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT fernandezveledosonia fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT vendrelljoan fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness AT gonzalezclementejosemiguel fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness |